| Code | Close | Market Cap | Chg % | RPS50 | RPS120 | RPS250 | Industry | Concepts |
|---|---|---|---|---|---|---|---|---|
Pfizer PFE | 25.38 | 144.29B | +0.24% | 43 | 48 | 44 | Drug Manufacturers - General | CAR-T Therapy;Cancer Research;Weight Loss Drugs;Infectious Disease |
Novartis AG NVS | 121.9 | 238.83B | -1.54% | 36 | 70 | 54 | Drug Manufacturers - General | CAR-T Therapy;Cancer Research |
Merck & Co MRK | 80.93 | 203.22B | -1.77% | 31 | 31 | 24 | Drug Manufacturers - General | ESG Investing;Cancer Research;Infectious Disease |
Gilead Sciences GILD | 111.75 | 139.01B | +0.22% | 40 | 83 | 87 | Drug Manufacturers - General | CAR-T Therapy;Cancer Research;Infectious Disease;Mpox (monkeypox) |
Exact Sciences EXAS | 53.36 | 10.07B | -0.93% | 69 | 39 | 72 | Diagnostics & Research | ARK Portfolio;Cancer Research;AI medical concept stocks |
| 128.35 | 8.29B | +0.12% | 89 | 91 | 67 | Biotechnology | Cancer Research | |
| 46.92 | 95.49B | -0.19% | 19 | 35 | 60 | Drug Manufacturers - General | Cancer Research | |
Biogen BIIB | 132.87 | 19.47B | -0.24% | 54 | 31 | 16 | Drug Manufacturers - General | Cancer Research |
Accuray ARAY | 1.42 | 146.28M | +2.16% | 14 | 15 | 28 | Medical Devices | Robotics;Cancer Research |